# Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

**Authors:** Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, Martin Sattler, Melissa Arn, Claudia Luckner-Minden, Henning Schulze-Bergkamen, Inka Zörnig, Frederik Marme, Andreas Schneeweiss, Michael H. Cardone, Joseph T. Opferman, Dirk Jäger, Klaus Podar

PMC · DOI: 10.1186/s13058-024-01811-y · 2024-04-02

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, MCL1 (MCL1 apoptosis regulator, BCL2 family member) [NCBI Gene 4170] {aka BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1}
- **Diseases:** hypoxia (MESH:D000860), breast cancer (MESH:D001943)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10988845/full.md

---
Source: https://tomesphere.com/paper/PMC10988845